Immune reconstitution inflammatory syndrome and the influence of T regulatory cells: A cohort study in the Gambia

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Zaidi, Irfan ^a   Peterson, Kevin ^a,b   Jeffries, David ^a   Whittle, Hilton ^a   de Silva, Thushan ^a,c   Rowland Jones, Sarah ^c   Jaye, Assan ^a   de Jong, Bouke C ^a,b,d  

^a Medical Research Council (UK) Unit   (Gambia)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GAMBIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; REGULATORY T LYMPHOCYTE; VIRUS LOAD;

ADULT; COHORT STUDIES; FEMALE; GAMBIA; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-2; INTERLEUKIN-6; MALE; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84862666476     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039213     Document Type: Article

References (35)

1. Shelburne SA 3rd, Darcourt J, White AC Jr, Greenberg SB, Hamill RJ, et al (2005) The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 40: 1049-1052.
2. French MA, Price P, Stone SF, (2004) Immune restoration disease after antiretroviral therapy. AIDS 18: 1615-1627.
3. Lawn SD, Bekker LG, Miller RF, (2005) Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. The Lancet infectious diseases 5: 361-373.
4. Murdoch DM, Venter WD, Van Rie A, Feldman C, (2007) Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS research and therapy 4: 9.
5. Muller M, Wandel S, Colebunders R, Attia S, Furrer H, et al. (2010) Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. The Lancet infectious diseases 10: 251-261.
6. Murdoch DM, Venter WD, Feldman C, Van Rie A, (2008) Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study. AIDS 22: 601-610.
7. Haddow LJ, Easterbrook PJ, Mosam A, Khanyile NG, Parboosing R, et al. (2009) Defining immune reconstitution inflammatory syndrome: evaluation of expert opinion versus 2 case definitions in a South African cohort. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 49: 1424-1432.
8. Valin N, Pacanowski J, Denoeud L, Lacombe K, Lalande V, et al. (2010) Risk factors for 'unmasking immune reconstitution inflammatory syndrome' presentation of tuberculosis following combination antiretroviral therapy initiation in HIV-infected patients. AIDS 24: 1519-1525.
9. Ratnam I, Chiu C, Kandala NB, Easterbrook PJ, (2006) Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 42: 418-427.
10. Lawn SD, Wainwright H, Orrell C, (2009) Fatal unmasking tuberculosis immune reconstitution disease with bronchiolitis obliterans organizing pneumonia: the role of macrophages. AIDS 23: 143-145.
11. Bourgarit A, Carcelain G, Martinez V, Lascoux C, Delcey V, et al. (2006) Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients. AIDS 20: F1-7.
12. Bourgarit A, Carcelain G, Samri A, Parizot C, Lafaurie M, et al. (2009) Tuberculosis-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin-specific CD4 Th1 cells and KIR-negative gammadelta T cells. Journal of immunology 183: 3915-3923.
13. Antonelli LR, Mahnke Y, Hodge JN, Porter BO, Barber DL, et al. (2010) Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome. Blood 116: 3818-3827.
14. Barber DL, Mayer-Barber KD, Antonelli LR, Wilson MS, White S, et al. (2010) Th1-driven immune reconstitution disease in Mycobacterium avium-infected mice. Blood 116: 3485-3493.
15. Kestens L, Seddiki N, Bohjanen PR, (2008) Immunopathogenesis of immune reconstitution disease in HIV patients responding to antiretroviral therapy. Current opinion in HIV and AIDS 3: 419-424.
16. Khattri R, Cox T, Yasayko SA, Ramsdell F, (2003) An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nature immunology 4: 337-342.
17. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, et al. (2005) Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22: 329-341.
18. Hori S, Sakaguchi S, (2004) Foxp3: a critical regulator of the development and function of regulatory T cells. Microbes and infection/Institut Pasteur 6: 745-751.
19. Sakaguchi S, Miyara M, Costantino CM, Hafler DA, (2010) FOXP3+ regulatory T cells in the human immune system. Nature reviews Immunology 10: 490-500.
20. Sakaguchi S, (2004) Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annual review of immunology 22: 531-562.
21. Suffia IJ, Reckling SK, Piccirillo CA, Goldszmid RS, Belkaid Y, (2006) Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens. The Journal of experimental medicine 203: 777-788.
22. Meintjes G, Wilkinson KA, Rangaka MX, Skolimowska K, van Veen K, et al. (2008) Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome. American journal of respiratory and critical care medicine 178: 1083-1089.
23. Seddiki N, Sasson SC, Santner-Nanan B, Munier M, van Bockel D, et al. (2009) Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease. European journal of immunology 39: 391-403.
24. Meintjes G, Lawn SD, Scano F, Maartens G, French MA, et al. (2008) Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. The Lancet infectious diseases 8: 516-523.
25. Letang E, Miro JM, Nhampossa T, Ayala E, Gascon J, et al. (2011) Incidence and predictors of immune reconstitution inflammatory syndrome in a rural area of Mozambique. PloS one 6: e16946.
26. Jevtovic D, Salemovic D, Ranin J, Pesic I, Zerjav S, et al. (2005) The dissociation between virological and immunological responses to HAART. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 59: 446-451.
27. Grant PM, Komarow L, Andersen J, Sereti I, Pahwa S, et al. (2010) Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection. PloS one 5: e11416.
28. Montes M, Sanchez C, Lewis DE, Graviss EA, Seas C, et al. (2011) Normalization of FoxP3(+) regulatory T cells in response to effective antiretroviral therapy. The Journal of infectious diseases 203: 496-499.
29. Elliott JH, Vohith K, Saramony S, Savuth C, Dara C, et al. (2009) Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy. Clinical Infectious Diseases. 200: 1736-1745.
30. Sereti I, Rodger AJ, French MA, (2010) Biomarkers in immune reconstitution inflammatory syndrome: signals from pathogenesis. Curr Opin HIV AIDS 5(6): 504-10.
31. Tan DB, Yong YK, Tan YH, Kamarulzaman A, Tan AH, et al. (2008) Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis. HIV Med 9: 307-316.
32. Haddow LJ, Dibben O, Moosa MY, Borrow P, Easterbrook PJ, (2011) Circulating inflammatory biomarkers can predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome. Aids 25: 1163-1174.
33. Lawn SD, Meintjes G, (2011) Pathogenesis and prevention of immune reconstitution disease during antiretroviral therapy. Expert review of anti-infective therapy 9: 415-430.
34. Alabi AS, Jaffar S, Ariyoshi K, Blanchard T, Schim van der Loeff M, et al. (2003) Plasma viral load, CD4 cell percentage, HLA and survival of HIV-1, HIV-2, and dually infected Gambian patients. AIDS 17: 1513-1520.
35. Berry N, Ariyoshi K, Jaffar S, Sabally S, Corrah T, et al. (1998) Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection. Journal of human virology 1: 457-468.